切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2017, Vol. 06 ›› Issue (03) : 127 -131. doi: 10.3877/cma.j.issn.2095-3216.2017.03.007

所属专题: 文献

论著

少量蛋白尿且无高血压的IgA肾病患者肾内小动脉玻璃样变相关因素分析
段姝伟1, 陈丁2, 吴杰1,(), 刘述文1, 郑颖1, 谢院生1, 蔡广研1   
  1. 1. 100853 解放军总医院肾脏病科、解放军肾脏病研究所、肾脏疾病国家重点实验室、国家慢性肾病临床医学研究中心
    2. 100089 北京,空军航空医学研究所附属医院
  • 收稿日期:2017-05-20 出版日期:2017-06-28
  • 通信作者: 吴杰
  • 基金资助:
    国家科技重大专项课题中药大品种技术改造与技术提升研究的子课题(2014ZX09201021-007); 北京市科委课题(Z161100000516225)

Correlation analysis of intrarenal arteriolar hyalinosis in IgA nephropathy with mild proteinuria and without hypertension

Shuwei Duan1, Ding Chen2, Jie Wu1,(), Shuwen Liu1, Ying Zheng1, Yuansheng Xie1, Guangyan Cai1   

  1. 1. Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases; Beijing 100853
    2. Affiliated Hospital of the PLA Aeromedicine Institute; Beijing 100089, China
  • Received:2017-05-20 Published:2017-06-28
  • Corresponding author: Jie Wu
  • About author:
    Corresponding author: Wu Jie, Email:
引用本文:

段姝伟, 陈丁, 吴杰, 刘述文, 郑颖, 谢院生, 蔡广研. 少量蛋白尿且无高血压的IgA肾病患者肾内小动脉玻璃样变相关因素分析[J/OL]. 中华肾病研究电子杂志, 2017, 06(03): 127-131.

Shuwei Duan, Ding Chen, Jie Wu, Shuwen Liu, Ying Zheng, Yuansheng Xie, Guangyan Cai. Correlation analysis of intrarenal arteriolar hyalinosis in IgA nephropathy with mild proteinuria and without hypertension[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2017, 06(03): 127-131.

目的

探索少量蛋白尿且无高血压的IgA肾病(IgAN)患者肾内小动脉玻璃样变(AH)相关因素。

方法

回顾性分析2010年1月1日至2014年12月31日在解放军总医院经肾穿刺活检、尿蛋白定量平均水平≤1 g/d且无高血压病史的原发性IgAN患者,采集患者肾穿刺活检前1周内的14项临床指标包括体质量指数、血压等,肾活检后的病理指标按照IgAN牛津分型更新版评价,根据是否伴有肾内AH病变将患者分为两组,比较组间临床、病理指标的差异,并采用logistic回归分析肾内AH病变相关因素。

结果

共纳入IgAN患者126例,其中伴有肾内AH病变的患者44例(34.92%)。伴肾内AH组患者的年龄、体质量指数、血尿酸、尿素氮、血肌酐水平均高于无肾内AH组患者,eGFR低于无肾内AH组患者(P均<0.05),慢性肾脏病分期和小管萎缩/间质纤维化病变在两组间分布也有差异(z=3.290, P=0.001; z=3.293, P=0.001)。多元logistic回归分析显示IgAN患者肾内AH病变相关因素有男性(OR 3.08,95%CI 1.03~9.18)、年龄每增加10岁(OR 3.02,95%CI 1.79~5.07)、体质量指数每增加10 kg/m2(OR 7.08,95%CI 1.54~32.42)和肾小管萎缩/间质纤维化病变(OR 5.96,95%CI 2.11~16.80)。

结论

蛋白尿少于≤1 g/d且无高血压的IgAN患者中发生肾内AH病变并不少见。男性、增龄、超重和肾小管萎缩/间质纤维化病变是此组IgAN患者肾内AH病变的相关因素。

Objective

To explore the correlation of intrarenal arteriolar hyalinosis (AH) with clinical and pathological indicators in IgA nephropathy (IgAN) with mild proteinuria and without hypertension.

Methods

Retrospective analysis was performed in patients with newly biopsy-confirmed IgAN between January 1, 2010 and December 31, 2014 in the Department of Nephrology, Chinese PLA General Hospital. The patients′ clinical data during the week before renal biopsy were collected. Pathological lesions were evaluated according to the updated Oxford Classification. Patients were divided into intrarenal AH group and non-AH group. Clinical and pathological indictors were compared between the two groups. The correlation of intrarenal AH with clinical and pathological indicators was analyzed using multivariant logistic regression method.

Results

A total of 126 IgAN cases without hypertension were enrolled, among whom 44 (34.92%) cases had intrarenal AH. All the 126 cases had proteinuria ≤1 g/d. The age, body mass index, serum uric acid, urea nitrogen, and creatinine were higher in intrarenal AH group than in non-AH group (P<0.05). And eGFR of intrarenal AH group was lower than that of non-AH group (P<0.05). There were significant differences in chronic kidney disease stages and tubular atrophy/interstitial fibrosis between the two groups (z=3.290, P=0.001; z=3.293, P=0.001). Multivariant logistic regression analysis showed that intrarenal AH of IgAN was correlated with male (OR 3.08, 95%CI 1.03-9.18), each age increase by 10 years (OR 3.02, 95%CI 1.79-5.07), each body mass index increase by 10 kg/m2 (OR 7.08, 95%CI 1.54-32.42), and tubular atrophy/interstitial fibrosis (OR 5.96, 95%CI 2.11-16.80).

Conclusion

It is not uncommon for IgAN patients with mild proteinuria and without hypertension to have intrarenal AH. Gender, age, body mass index, and tubular atrophy/interstitial fibrosis were correlated with intrarenal AH of IgAN.

表1 入组IgA肾病患者的临床特征[±s或例数(%)]
表2 入组IgA肾病患者的病理特征[例数(%)]
表3 入组IgA肾病患者肾内小动脉玻璃样变与临床、病理指标的单因素logistic回归分析
表4 入组IgA肾病患者肾内小动脉玻璃样变与临床、病理指标的多因素logistic回归分析
图1 肾小球入出球小动脉玻璃样变(PAS×400)
图2 肾间质小动脉玻璃样变伴肾小管萎缩(PAS×400)
[11]
Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group [J]. Kidney Int,2017,91(5): 1014-1021.
[12]
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility [J]. Kidney Int,2009,76(5): 546-556.
[13]
Gamble CN. The pathogenesis of hyaline arteriolosclerosis [J]. Am J Pathol,1986,122(3): 410-420.
[14]
Sund S, Reisaeter AV, Scott H, et al. Morphological studies of baseline needle biopsies from living donor kidneys: light microscopic, immunohistochemical and ultrastructural findings [J]. APMIS,1998,106(11): 1017-1034.
[15]
Morrissey JJ. Direct or indirect endothelial cell transforming growth factor-beta receptor activation initiates arteriolar hyalinosis [J]. Kidney Int,2012,82(8): 838-839.
[16]
李明喜,Nicholl K.肾移植供者的肾小动脉病变和肾小球硬化[J]. 肾脏病与透析肾移植杂志,2001,10(3): 228-232.
[17]
Myllymaki J, Honkanen T, Syrjanen J, et al. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy [J]. Nephrol Dial Transplant,2005,20(1): 89-95.
[18]
Pannarale G, Carbone R, Del Mastro G, et al. The aging kidney: structural changes [J]. J Nephrol,2010,23(Suppl 15): S37-S40.
[19]
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification [J]. Kidney Int,2009,76(5): 534-545.
[20]
Coppo R, Troyanov S, Bellur S, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments [J]. Kidney Int,2014,86(4): 828-836.
[21]
Azancot MA, Moreso F, Salcedo M, et al. The reproducibility and predictive value on outcome of renal biopsies from expanded criteria donors [J]. Kidney Int,2014,85(5): 1161-1168.
[22]
Seron D, Moreso F. Transplant vasculopathy in early protocol renal allograft biopsies [J]. Transplant Proc,1999,31(6): 2219-2220.
[1]
D′Amico G. The commonest glomerulonephritis in the world: IgA nephropathy [J]. Q J Med,1987,64(245): 709-727.
[2]
Zhang L, Zuo L. Current burden of end-stage kidney disease and its future trend in China [J]. Clin Nephrol,2016,86 (13): 27-28.
[3]
Wu J, Chen X, Xie Y, et al. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy [J]. Nephrol Dial Transplant,2005,20(4): 719-727.
[4]
Kaneko Y, Yoshita K, Kono E, et al. Extracapillary proliferation and arteriolar hyalinosis are associated with long-term kidney survival in IgA nephropathy [J]. Clin Exp Nephrol,2016,20(4): 569-577.
[5]
Kashgarian M. Pathology of small blood vessel disease in hypertension [J]. Am J Kidney Dis,1985,5(4): A104-A110.
[6]
Zamami R, Kohagura K, Miyagi T, et al. Modification of the impact of hypertension on proteinuria by renal arteriolar hyalinosis in nonnephrotic chronic kidney disease [J]. J Hypertens,2016,34(11): 2274-2279.
[7]
Matos AC, Camara NO, LR RE-M, et al. Presence of arteriolar hyalinosis in post-reperfusion biopsies represents an additional risk to ischaemic injury in renal transplant [J]. Nephrology (Carlton),2016,21(11): 923-929.
[8]
Cook HT. Interpretation of renal biopsies in IgA nephropathy [J]. Contrib Nephrol,2007,157: 44-49.
[9]
Olson JL. Hyaline arteriolosclerosis: new meaning for an old lesion [J]. Kidney Int,2003,63(3): 1162-1163.
[10]
Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities [J]. Kidney Int,2011,79(5): 555-562.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 宋勤琴, 李双汝, 李林, 杜鹃, 刘继松. 间充质干细胞源性外泌体在改善病理性瘢痕中作用的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 550-553.
[3] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[4] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[5] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[6] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[7] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[8] 丁富贵, 吴泽涛, 董卫国. 家族性腺瘤性息肉病临床特征及生物信息学分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 512-518.
[9] 张立俊, 孙存杰, 胡春峰, 孟冲, 张辉. MSCT、DCE-MRI 评估术前胃癌TNM 分期的准确性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 519-523.
[10] 甘曦, 廖鑫. 胃癌旁肿瘤沉积与CT影像学特征、血清指标及病理特征的关联性分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 422-425.
[11] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[12] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
[13] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
[14] 金安松, 邹玉松, 刘玖涛, 薛凤麟, 庞爱兰. 孤立性颅内浆细胞瘤一例及相关文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 495-500.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要